Literature DB >> 11990885

The role of early warning symptoms in the detection and prevention of relapse in schizophrenia.

P B Fitzgerald1.   

Abstract

OBJECTIVE: The capacity of most clinical programs to detect early signs of relapse in schizophrenia and to implement strategies to prevent clinical progression remains unevaluated. The aim of this paper is to review the literature on the detection of relapse in schizophrenia and to draw conclusions that may be of use in the implementation of clinical programs.
METHOD: The relevant literature identified by standard search methods is explored and analysed.
RESULTS: Few studies have the capacity to directly address the question as to whether it is possible to predict relapse with a high degree of predictive power. Recently, the implementation of a multifactorial approach to relapse prediction appears to have offered substantial benefits.
CONCLUSIONS: The prediction of episodes of psychotic relapse is a realistic goal. Evidence indicates that interventions based upon programs of early detection can reduce rates of illness relapse. Prediction of relapse is most successful when implemented in a multifactorial way that involves specific and non-specific symptoms, structured ratings, clinical judgement, families, patients and clinicians.

Entities:  

Mesh:

Year:  2001        PMID: 11990885     DOI: 10.1046/j.1440-1614.2001.00962.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  2 in total

1.  Prediction of the period of psychotic episode in individual schizophrenics by simulation-data construction approach.

Authors:  Chun-Jung Huang; Hsiao-Fan Wang; Hsien-Jane Chiu; Tsuo-Hung Lan; Tsung-Ming Hu; El-Wui Loh
Journal:  J Med Syst       Date:  2009-05-29       Impact factor: 4.460

2.  Packages of care for schizophrenia in low- and middle-income countries.

Authors:  Mari Jair de Jesus; Denise Razzouk; Rangaswamy Thara; Julian Eaton; Graham Thornicroft
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.